TenSixteen Bio

Recent Finacing

Equity

Recent Raise

$40M

TenSixteen Bio builds an R&D ecosystem around somatic mosaicism and clonal hematopoiesis, combining multi-omics and clinical data, a proprietary CHIP diagnostic assay, and trial networks to discover targeted therapeutics.

Founded 2020

California, United States

11-50

Private

tensixteen.bio

Highlights

Focus Areas

Biotechnology

Health Care

Therapeutics

Recent Investors

Financials

$40M

Total Raised

1

Funding round

2

Investors

Team

Upgrade to view the team

See the team members at TenSixteen Bio.